Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

Graham Ogg photo

Professor Graham Ogg is one of 11 University of Oxford biomedical and health scientists elected to the Academy of Medical Sciences Fellowship.

Professor Ogg has led ground-breaking research into COVID-19 immune responses, as well as continuing with his research into the role of human cutaneous immune responses in mechanisms of disease, treatment and vaccination. He is currently collaborating with colleagues in Sri Lanka to compare COVID-19 responses in different populations, to uncover the role of 'background' immunity to virus strains already in circulation. He has also co-led a study demonstrating that individuals with mild COVID-19 had a different pattern of T cell response when compared to those with more severe infection.

Professor Ogg was also the first recipient of the now annual RDM awards for excellent supervision, with members of his team commending him for 'his incredible enthusiasm and optimism', and for always having time to meet people and provide prompt and excellent feedback. 

Professor Ogg said "I am delighted to have received such a prestigious honour, which really reflects a group effort with my terrific team in the MRC Human Immunology Unit."

Many congratulations to Professor Ogg!

Read the full story on the Oxford University website

Similar stories

Many Long COVID patients continue to experience symptoms one year after hospital discharge

People who were hospitalised with COVID-19 and continued to experience symptoms five months later, show limited further recovery one year after hospital discharge according to the latest results of a major national study.

Spin-out company Alethiomics launches

The enterprise will focus on developing targeted therapies for a specific family of blood cancers.

Interview with Excellence Award winner Dr Susan Shapiro

A member of the Oxford Centre For Haematology, Dr Shapiro, was recently interviewed by the Royal College of Pathologists.

Iron integral to the development of life on Earth – and the possibility of life on other planets

A collaboration between researchers at the MRC WIMM and Department of Earth Sciences uncovers the importance of iron for the development of complex life on Earth.

Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease

Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.